Dimensional Fund Advisors LP Revance Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$11.52 - $20.4 $1.13 Million - $2 Million	-98,129 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$12.36 - $20.31 $414,455 - $681,034	-33,532 Reduced 25.47%	98,129 $1.91 Million
Q4 2021 Feb 09, 2022	BUY	$12.46 - $27.87 $109,660 - $245,283	8,801 Added 7.16%	131,661 $2.15 Million
Q3 2021 Nov 12, 2021	SELL	$25.78 - $33.21 $691,522 - $890,825	-26,824 Reduced 17.92%	122,860 $3.42 Million
Q2 2021 Aug 12, 2021	BUY	$26.8 - $31.84 $4.01 Million - $4.77 Million	149,684 New	149,684 $4.44 Million
Q1 2021 May 14, 2021	SELL	$24.03 - $29.97 $11.7 Million - $14.6 Million	-487,436 Closed	0 $0
Q4 2020 Feb 25, 2021	BUY	$23.41 - $28.34 $11.4 Million - $13.8 Million	487,436 New	487,436 $13.8 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.